MICHELLE STROUP: Open Payments
NPI 1174155683 · APEX, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 44 payments from 11 companies in 2025. Trend: 2023 $838 · 2024 $1,038 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $163 |
| Lilly USA, LLC | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Amgen Inc. | 4 | $64 |
| ABBVIE INC. | 3 | $42 |
| PFIZER INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $23 |
| PhotoniCare Inc | 1 | $23 |
Products named: CAPLYTA, Wegovy, Ozempic, ZEPBOUND, AIRSUPRA, NURTEC ODT, FARXIGA, OTEZLA.
Industry payments across NC — which companies pay providers there.
